menu search

CDXS / Codexis Shares Slide On CEO Transition

Codexis Shares Slide On CEO Transition
Codexis, Inc. (NASDAQ: CDXS) has appointed Dr. Stephen Dilly, Board member, and biotechnology veteran, as President and CEO, effective August 9, 2022. After ten years of leading the transformation and growth of Codexis, the current President and CEO, John Nicols, will step down for. Read More
Posted: Jul 18 2022, 17:07
Author Name: Benzinga
Views: 110821

CDXS News  

Codexis, Inc. (CDXS) Q3 2023 Earnings Call Transcript

By Seeking Alpha
November 2, 2023

Codexis, Inc. (CDXS) Q3 2023 Earnings Call Transcript

Codexis, Inc. (CDXS) Q3 2023 Earnings Call Transcript more_horizontal

Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe

By GlobeNewsWire
October 27, 2023

Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe

REDWOOD CITY, Calif., Oct. 27, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced a presenta more_horizontal

Checking Out Codexis

By Seeking Alpha
October 5, 2023

Checking Out Codexis

Codexis, Inc. is undergoing a significant restructuring to reduce costs, refocus its developmental efforts and streamline its organization. The compan more_horizontal

Codexis (CDXS) Transfers Leasing Rights to Vaxcyte, Stock Up

By Zacks Investment Research
September 11, 2023

Codexis (CDXS) Transfers Leasing Rights to Vaxcyte, Stock Up

Codexis (CDXS) transfers the leasing rights of its San Carlos, CA location to Vaxcyte to focus on technology development, inducing cost savings, to ex more_horizontal

Codexis, Inc. (CDXS) Q4 2022 Earnings Call Transcript

By Seeking Alpha
February 23, 2023

Codexis, Inc. (CDXS) Q4 2022 Earnings Call Transcript

Codexis, Inc. (NASDAQ:CDXS ) Q4 2022 Earnings Conference Call February 23, 2023 4:30 PM ET Company Participants Stephen Dilly - President, CEO & Direc more_horizontal

Codexis (CDXS) Reports Q4 Loss, Tops Revenue Estimates

By Zacks Investment Research
February 23, 2023

Codexis (CDXS) Reports Q4 Loss, Tops Revenue Estimates

Codexis (CDXS) delivered earnings and revenue surprises of 17.39% and 4.30%, respectively, for the quarter ended December 2022. Do the numbers hold cl more_horizontal

Codexis, Inc. (CDXS) Q3 2022 Earnings Call Transcript

By Seeking Alpha
November 5, 2022

Codexis, Inc. (CDXS) Q3 2022 Earnings Call Transcript

Codexis, Inc. (NASDAQ:CDXS ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Brendan Strong - Argot Partners Dr. Ste more_horizontal

Codexis (CDXS) Reports Q3 Loss, Tops Revenue Estimates

By Zacks Investment Research
November 3, 2022

Codexis (CDXS) Reports Q3 Loss, Tops Revenue Estimates

Codexis (CDXS) delivered earnings and revenue surprises of 16.67% and 9.74%, respectively, for the quarter ended September 2022. Do the numbers hold c more_horizontal


Search within

Pages Search Results: